IDEXX Laboratories, Inc.
0J8P.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$41.02B
Close$
$123.88
76.5% downside
Current Fair Value
76.5% downsideOvervalued by 76.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $41.02 Billion |
|---|---|
| Enterprise Value | $41.83 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $13.17 |
| Beta | 1.5 |
| Outstanding Shares | 78,954,000 |
Return
| Return on Equity | 70.67% |
|---|---|
| Return on Assets | 33.11% |
| Return on Invested Capital | 67.81% |
Valuation & Multiples
| P/E Ratio | 36.38 |
|---|---|
| PEG | 240.74 |
| Price to Sales | 9.25 |
| Price to Book Ratio | 26.37 |
| Enterprise Value to Revenue | 9.19 |
| Enterprise Value to EBIT | 28.63 |
| Enterprise Value to Net Income | 36 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.62 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$3.94
Average shareholder expectationRevenue Estimate
$1.20 B
Average shareholder expectationNext Earnings Call
Expected Date
November 2, 2026
EPS Estimate
$3.71
Average shareholder expectationRevenue Estimate
$1.19 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Idexx Laboratories, Inc.
11,000 employees
CEO: Jonathan Jay Mazelsky IDEXX Laboratories, Inc. is a global enterprise dedicated to creating, producing, and distributing a broad spectrum of products and services. Its primary focus lies in serving the companion animal veterinary, livestock and poultry, dairy...